Search bioRxivSearch

bioRxiv · 10.1101/432633

In vivo cerebral microdialysis validation of the acute central glutamate response in a translational rat model of concussion combining force and rotation

Abstract

Concussions/mild traumatic brain injury (mTBI) represent a major public health concern due to persistent behavioral and neurological effects. The mechanisms by which concussions lead to such effects are partly attributable to an hyperacute indiscriminate glutamate release. Cerebral microdialysis studies in rodents reported a peak of extracellular glutamate 10 minutes after injury. Microdialysis has the advantage of being one of the few techniques allowing the quantification of neurotransmitters in vivo and at different time points following injury. In addition to the clear advantages afforded by microdialysis, the Wayne State weight-drop model induces an impact on the skull of a subject unrestrained by the fall of a weight. The latter model allows rapid acceleration and deceleration of the head and torso, an essential feature in human craniocerebral trauma and a factor that is missing from many existing animal concussion models. In the present study, we applied the Wayne State procedure and microdialysis to document, in awake rats, the acute changes in extracellular hippocampal glutamate and GABA levels resulting from concussive trauma. We studied the dorsal CA1 hippocampal region as it contains a high density of glutamatergic terminal and receptors, thus making it vulnerable to excitotoxic insult. Using HPLC, dialysate levels of hippocampal glutamate and GABA were measured in adult male Sprague-Dawley rats in 10 min increments for 60 min prior to, during and for 90 min following concussive trauma induced by the Wayne State weight-drop procedure. Sham control animals were treated in the same manner but without receiving the concussive trauma procedure. Our results show that concussive trauma is followed, within 10 min, by a robust, transient 3-fold increase in hippocampal glutamate levels; such changes were not seen in controls. In contrast, GABA levels were unaffected by the concussive trauma procedure. The findings derived from the approach used here are generally consistent with those of previous other studies. They also provide a crucial in vivo validation of the Wayne State procedure as a model with promising translational potential for pre-clinical studies on early therapeutic responses to concussion.

Explore related subjects

Keep this discovery

BibTeXRIS

Masse, I. O., Moquin, L., Provost, C., Guay, S., Gratton, A., De Beaumont, L.. 2018-10-01. In vivo cerebral microdialysis validation of the acute central glutamate response in a translational rat model of concussion combining force and rotation. https://doi.org/10.1101/432633

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience